Evidence map›Paper›PMID 33857200›Full record

ArticlePloS one2021

OptiMissP: A dashboard to assess missingness in proteomic data-independent acquisition mass spectrometry.

Angelica Arioli, Arianna Dagliati, Bethany Geary, Niels Peek, Philip A Kalra, Anthony D Whetton, Nophar Geifman

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Angelica ArioliDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
Arianna DagliatiDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
Bethany GearyDivision of Cancer Sciences, Stoller Biomarker Discovery Centre, Manchester, United Kingdom.
Niels PeekDivision of Informatics, Imaging, and Data Science, School of Health Sciences, The University of Manchester, Manchester, United Kingdom.
Philip A KalraSalford Royal NHS Foundation Trust, Salford, United Kingdom.
Anthony D WhettonDivision of Cancer Sciences, Stoller Biomarker Discovery Centre, Manchester, United Kingdom.
Nophar GeifmanDivision of Informatics, Imaging, and Data Science, School of Health Sciences, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0003-2956-6676

Funding

Cancer Research UK C5759/A25254Department of HealthMedical Research Council MR/M008959/1Medical Research Council MR/N00583X/1Medical Research Council MR/R013942/1
6 · The paper itself

Abstract

backgroundMissing values are a key issue in the statistical analysis of proteomic data. Defining the strategy to address missing values is a complex task in each study, potentially affecting the quality of statistical analyses.

resultsWe have developed OptiMissP, a dashboard to visually and qualitatively evaluate missingness and guide decision making in the handling of missing values in proteomics studies that use data-independent acquisition mass spectrometry. It provides a set of visual tools to retrieve information about missingness through protein densities and topology-based approaches, and facilitates exploration of different imputation methods and missingness thresholds.

conclusionsOptiMissP provides support for researchers' and clinicians' qualitative assessment of missingness in proteomic datasets in order to define study-specific strategies for the handling of missing values. OptiMissP considers biases in protein distributions related to the choice of imputation method and helps analysts to balance the information loss caused by low missingness thresholds and the noise introduced by selecting high missingness thresholds. This is complemented by topological data analysis which provides additional insight to the structure of the data and their missingness. We use an example in Chronic Kidney Disease to illustrate the main functionalities of OptiMissP.

Indexed as

SoftwareBiasComputer SimulationData Interpretation, StatisticalHumansMass SpectrometryModels, StatisticalProteomics

Identifiers

PMID33857200
PMCPMC8049317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.